Genmab AS (GMAB)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current GMAB market cap is 18.59B. The company's latest EPS is DKK 6.5865 and P/E is 42.48.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Total Revenue | 2.85B | 4.2B | 4.74B | 4.68B | 4.14B |
| Operating Income | 437M | 1.5B | 1.72B | -693M | 801M |
| Net Income | 226M | 1.36B | 2.13B | 640M | 1.33B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Total Revenue | 5.37B | 10.11B | 8.48B | 14.6B | 16.47B |
| Operating Income | 2.64B | 6.31B | 3.02B | 6.36B | 5.32B |
| Net Income | 2.17B | 4.76B | 3.01B | 5.52B | 4.35B |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Total Assets | 30.39B | 31.98B | 35.24B | 35.29B | 36.68B |
| Total Liabilities | 3.2B | 3.22B | 4.13B | 3.68B | 4.18B |
| Total Equity | 27.19B | 28.76B | 31.11B | 31.61B | 32.5B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Total Assets | 15.14B | 21.14B | 24.63B | 30.28B | 35.29B |
| Total Liabilities | 1.1B | 2.02B | 2.43B | 2.84B | 3.68B |
| Total Equity | 14.05B | 19.12B | 22.2B | 27.44B | 31.61B |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Operating | 3.24B | 3.67B | 5.71B | 7.38B | 1.51B |
| Investing | -13M | -1.85B | -840M | -1.28B | -1.44B |
| Financing | -611M | -604M | -584M | -606M | -595M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Operating | 1.33B | 6.43B | 2.23B | 3.91B | 7.38B |
| Investing | -1.98B | -2.35B | -961M | -2.76B | -1.28B |
| Financing | 3.66B | 71M | -420M | -789M | -606M |
| Market Cap | 18.59B |
| Price to Earnings Ratio | 42.48 |
| Price to Sales Ratio | 11.22 |
| Price to Cash Ratio | 12.44 |
| Price to Book Ratio | 5.85 |
| Dividend Yield | - |
| Shares Outstanding | 660.75M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.03 (0.11%) |
| Company Name | Genmab AS |
| Address |
kalvebod brygge 43 copenhagen 1260 |
| Website | https://www.genmab.com |
| Industry | biogenetic (human) (H4) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
